Valion Bio (VBIO) Enterprise Value (QoQ) (2022 - 2025)
Valion Bio (VBIO) Enterprise Value (QoQ) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Valion Bio | 420,133.64 | -1.78 Mn | -45,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -265.22% |
| Sep 30, 2025 | -191.39% |
| Jun 30, 2025 | -76.98% |
| Mar 31, 2025 | 66.58% |
| Dec 31, 2024 | 4.67% |
| Sep 30, 2024 | 35.15% |
| Jun 30, 2024 | -160.50% |
| Mar 31, 2024 | 61.67% |
| Dec 31, 2023 | 31.63% |
| Sep 30, 2023 | -118.47% |
| Jun 30, 2023 | 56.58% |
| Mar 31, 2023 | -42.17% |
| Dec 31, 2022 | 44.42% |
| Sep 30, 2022 | 29.69% |
| Jun 30, 2022 | 12.98% |
| Mar 31, 2022 | 19.15% |